ZITHROMAX 6 Dosage Forms, Strengths, Composition And Packaging

azithromycin dihydrate

(
Table – Dosage Forms, Strengths, Composition and Packaging
Route of AdministrationDosage Form / Strength/CompositionNon-medicinal Ingredients
OralTablet, 250 mg and 600 mg azithromycin (as azithromycin dihydrate)pregelatinized starch, sodium croscarmellose, sodium lauryl sulphate and lactose
Powder for oral suspension, azithromycin 100 mg/5 mL, 200 mg/5 mL when reconstituted (as azithromycin dihydrate)sucrose and sodium phosphate
IntravenousAzithromycin for injection, 500 mg/vial, (100 mg/mL after reconstitution) (as azithromycin dihydrate)sodium hydroxide for pH adjustment

TABLETS 250 mg: Each pink, film-coated, unscored, modified capsule shaped ZITHROMAX tablet, engraved “ZTM 250” or “306”  on one side and “Pfizer” on the other side, contains azithromycin dihydrate equivalent to 250 mg of azithromycin and the following inactive ingredients: pregelatinized starch (27 mg), anhydrous calcium phosphate dibasic, sodium croscarmellose (9 mg), magnesium stearate, sodium lauryl sulphate, hydroxypropyl methylcellulose, lactose (tablet coating), titanium dioxide, triacetin and D&C Red #30 aluminum lake.  The tablets are packaged in white plastic (high density polyethylene) bottles of 30 or in a single treatment package (Z-pak) of 6 blister packaged tablets per box.

TABLETS 600 mg:  Each white, film-coated, unscored, modified oval shaped ZITHROMAX tablet, debossed with “PFIZER” on one side and “308” on the other side, contains azithromycin dihydrate equivalent to 600 mg azithromycin and the following non-medicinal ingredients: anhydrous calcium phosphate dibasic, pregelatinized starch (64.8 mg), sodium croscarmellose (21.6 mg), magnesium stearate, sodium lauryl sulphate, hydroxypropyl methylcellulose, lactose (tablet coating), titanium dioxide and triacetin.  These are packaged in HDPE bottles of 30 tablets.

POWDER FOR ORAL SUSPENSION: ZITHROMAX Powder for Oral Suspension, contains azithromycin dihydrate equivalent to: 300 mg; 600 mg; and 900 mg of azithromycin per bottle.  After reconstitution, each bottle (high density polyethylene) contains a cherry flavoured suspension with azithromycin dihydrate equivalent to: 300 mg per 15 mL (100 mg/5 mL); 600 mg per 15 mL (200 mg/5 mL); 900 mg per 22.5 mL (200 mg/5 mL) azithromycin.  The non-medicinal ingredients include: sucrose (3.86 g per 100 mg/5 mL and 3.87 g per 200 mg/5 mL); sodium phosphate (8.76 mg per 100 mg/5 mL and 17.50 mg per 200 mg/5 mL), tribasic hydroxypropyl cellulose; xanthan gum; FD&C Red #40 and artificial flavours (see 4.3 Reconstitution).  The 300 mg bottle (100 mg/5 mL) is supplied with a plastic stopper and a calibrated syringe.  The 600 mg bottle (200 mg/5 mL) and the 900 mg bottle (200 mg/5 mL) are supplied with a plastic stopper, and a calibrated syringe and dosing cup.

ZITHROMAX for Injection 500 mg:  Each vial contains azithromycin dihydrate in a lyophilized form equivalent to 500 mg azithromycin for injection.  The non-medicinal ingredients include: 384.6 mg anhydrous citric acid and 198.5 mg sodium hydroxide for pH adjustment.  After reconstitution, each mL contains azithromycin dihydrate equivalent to 100 mg azithromycin (500 mg/5 mL) (see 4.3 Reconstitution). ZITHROMAX for Injection is supplied in cartons of 10 single dose vials.

)

Find ZITHROMAX medical information:

Find ZITHROMAX medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ZITHROMAX Quick Finder

Product Monograph
Download Product Monograph

Health Professional Information

6 Dosage Forms, Strengths, Composition And Packaging

Table – Dosage Forms, Strengths, Composition and Packaging
Route of AdministrationDosage Form / Strength/CompositionNon-medicinal Ingredients
OralTablet, 250 mg and 600 mg azithromycin (as azithromycin dihydrate)pregelatinized starch, sodium croscarmellose, sodium lauryl sulphate and lactose
Powder for oral suspension, azithromycin 100 mg/5 mL, 200 mg/5 mL when reconstituted (as azithromycin dihydrate)sucrose and sodium phosphate
IntravenousAzithromycin for injection, 500 mg/vial, (100 mg/mL after reconstitution) (as azithromycin dihydrate)sodium hydroxide for pH adjustment

TABLETS 250 mg: Each pink, film-coated, unscored, modified capsule shaped ZITHROMAX tablet, engraved “ZTM 250” or “306”  on one side and “Pfizer” on the other side, contains azithromycin dihydrate equivalent to 250 mg of azithromycin and the following inactive ingredients: pregelatinized starch (27 mg), anhydrous calcium phosphate dibasic, sodium croscarmellose (9 mg), magnesium stearate, sodium lauryl sulphate, hydroxypropyl methylcellulose, lactose (tablet coating), titanium dioxide, triacetin and D&C Red #30 aluminum lake.  The tablets are packaged in white plastic (high density polyethylene) bottles of 30 or in a single treatment package (Z-pak) of 6 blister packaged tablets per box.

TABLETS 600 mg:  Each white, film-coated, unscored, modified oval shaped ZITHROMAX tablet, debossed with “PFIZER” on one side and “308” on the other side, contains azithromycin dihydrate equivalent to 600 mg azithromycin and the following non-medicinal ingredients: anhydrous calcium phosphate dibasic, pregelatinized starch (64.8 mg), sodium croscarmellose (21.6 mg), magnesium stearate, sodium lauryl sulphate, hydroxypropyl methylcellulose, lactose (tablet coating), titanium dioxide and triacetin.  These are packaged in HDPE bottles of 30 tablets.

POWDER FOR ORAL SUSPENSION: ZITHROMAX Powder for Oral Suspension, contains azithromycin dihydrate equivalent to: 300 mg; 600 mg; and 900 mg of azithromycin per bottle.  After reconstitution, each bottle (high density polyethylene) contains a cherry flavoured suspension with azithromycin dihydrate equivalent to: 300 mg per 15 mL (100 mg/5 mL); 600 mg per 15 mL (200 mg/5 mL); 900 mg per 22.5 mL (200 mg/5 mL) azithromycin.  The non-medicinal ingredients include: sucrose (3.86 g per 100 mg/5 mL and 3.87 g per 200 mg/5 mL); sodium phosphate (8.76 mg per 100 mg/5 mL and 17.50 mg per 200 mg/5 mL), tribasic hydroxypropyl cellulose; xanthan gum; FD&C Red #40 and artificial flavours (see 4.3 Reconstitution).  The 300 mg bottle (100 mg/5 mL) is supplied with a plastic stopper and a calibrated syringe.  The 600 mg bottle (200 mg/5 mL) and the 900 mg bottle (200 mg/5 mL) are supplied with a plastic stopper, and a calibrated syringe and dosing cup.

ZITHROMAX for Injection 500 mg:  Each vial contains azithromycin dihydrate in a lyophilized form equivalent to 500 mg azithromycin for injection.  The non-medicinal ingredients include: 384.6 mg anhydrous citric acid and 198.5 mg sodium hydroxide for pH adjustment.  After reconstitution, each mL contains azithromycin dihydrate equivalent to 100 mg azithromycin (500 mg/5 mL) (see 4.3 Reconstitution). ZITHROMAX for Injection is supplied in cartons of 10 single dose vials.

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.

To report an adverse event related to COMIRNATY, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

Canada Vigilance Program 

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect